Literature DB >> 31467129

Early high plasma ST2, the decoy IL-33 receptor, in children undergoing hematopoietic cell transplantation is associated with the development of post-transplant diabetes mellitus.

Courtney M Rowan1, Alicia M Teagarden2, Daniel T Cater2, Elizabeth A S Moser3, Giorgos Baykoyannis3, Sophie Paczesny1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31467129      PMCID： PMC7193497          DOI： 10.3324/haematol.2019.222992

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  8 in total

1.  Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation.

Authors:  Patricia M Sheean; Sally A Freels; W Scott Helton; Carol A Braunschweig
Journal:  Biol Blood Marrow Transplant       Date:  2006-06       Impact factor: 5.742

Review 2.  Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.

Authors:  Nathalie Esser; Sylvie Legrand-Poels; Jacques Piette; André J Scheen; Nicolas Paquot
Journal:  Diabetes Res Clin Pract       Date:  2014-04-13       Impact factor: 5.602

3.  New-Onset Post-Transplant Diabetes Mellitus after Allogeneic Hematopoietic Cell Transplant Is Initiated by Insulin Resistance, Not Immunosuppressive Medications.

Authors:  Brian G Engelhardt; Ujjawal Savani; Dae Kwang Jung; Alvin C Powers; Madan Jagasia; Heidi Chen; Jason J Winnick; Robyn A Tamboli; James E Crowe; Naji N Abumrad
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-07       Impact factor: 5.742

4.  Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.

Authors:  Romany A N Johnpulle; Sophie Paczesny; Dae Kwang Jung; Etienne Daguindau; Madan H Jagasia; Bipin N Savani; Wichai Chinratanalab; Robert F Cornell; Stacey Goodman; John P Greer; Adetola A Kassim; Salyka Sengsayadeth; Michael T Byrne; Brian G Engelhardt
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-21       Impact factor: 5.742

5.  Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation.

Authors:  Michelle L Griffith; Madan H Jagasia; Amanda A Misfeldt; Heidi Chen; Brian G Engelhardt; Adetola Kassim; Bipin N Savani; Margaret Survant; Shubhada M Jagasia
Journal:  Biol Blood Marrow Transplant       Date:  2010-06-16       Impact factor: 5.742

6.  Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation.

Authors:  Shigeo Fuji; Sung-Won Kim; Shin-ichiro Mori; Takahiro Fukuda; Shigemi Kamiya; Satoshi Yamasaki; Yuriko Morita-Hoshi; Fusako Ohara-Waki; Osamu Honda; Setsuko Kuwahara; Ryuji Tanosaki; Yuji Heike; Kensei Tobinai; Yoichi Takaue
Journal:  Transplantation       Date:  2007-10-15       Impact factor: 4.939

7.  ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

Authors:  Mark T Vander Lugt; Thomas M Braun; Samir Hanash; Jerome Ritz; Vincent T Ho; Joseph H Antin; Qing Zhang; Chee-Hong Wong; Hong Wang; Alice Chin; Aurélie Gomez; Andrew C Harris; John E Levine; Sung W Choi; Daniel Couriel; Pavan Reddy; James L M Ferrara; Sophie Paczesny
Journal:  N Engl J Med       Date:  2013-08-08       Impact factor: 91.245

8.  Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction.

Authors:  Evangelos Fousteris; Andreas Melidonis; George Panoutsopoulos; Konstantinos Tzirogiannis; Stefanos Foussas; Anastasios Theodosis-Georgilas; Stavros Tzerefos; Spiridon Matsagos; Eleni Boutati; Theofanis Economopoulos; George Dimitriadis; Sotirios Raptis
Journal:  Cardiovasc Diabetol       Date:  2011-11-21       Impact factor: 9.951
  8 in total
  3 in total

Review 1.  Post-haematopoietic cell transplantation outcomes: why ST2 became a 'golden nugget' biomarker.

Authors:  Sophie Paczesny
Journal:  Br J Haematol       Date:  2020-02-10       Impact factor: 6.998

2.  Soluble Suppression of Tumorigenicity 2 is Directly Correlated with Glycated Hemoglobin in Individuals with an Average glycemia in the Normal/Prediabetes Range.

Authors:  Amal Hasan; Waleed Aldhahi
Journal:  Diabetes Metab Syndr Obes       Date:  2020-08-03       Impact factor: 3.168

3.  New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.

Authors:  Brendan L Mangan; Dilan Patel; Heidi Chen; Katie S Gatwood; Michael T Byrne; Salyka Sengsayadeth; Stacey Goodman; Bhagirathbhai Dholaria; Adetola A Kassim; Madan Jagasia; Wichai Chinratanalab; Kathryn A Culos; Brian G Engelhardt
Journal:  EJHaem       Date:  2020-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.